Category Archives: Pr Newswire

NEW YORK, Aug. 2, 2024 /PRNewswire/ — Lil Bub’s owner, Mike Bridavsky, is set to give his first interview in a year, sharing heartwarming stories about the beloved cat who captured millions of hearts worldwide. The interview, which will take place on Crypto Banter (tweet) is made possible by a generous donation from the Lil […]

World’s Leading Provider of Cutting-Edge Smart Ring Solutions NEW YORK, Aug. 2, 2024 /PRNewswire/ — RingConn today launches its Gen 2 Smart Ring on Kickstarter, featuring the first-ever integrated sleep apnea monitoring in a smart ring. This groundbreaking device offers 10 – 12 days battery life, compact hardware, and comprehensive health monitoring services. RingConn Gen […]

NEW HAVEN, CT, and MONMOUTH JUNCTION, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that the Company’s European Patent Application No. 17 771018.3 titled: “Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases” was granted by […]

Founder John J. Puisis to transition CEO role to current COO Dannielle Appelhans Mr. Puisis to remain on COUR Board of Directors CHICAGO, Aug. 01, 2024 (GLOBE NEWSWIRE) — COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, today announced that as part of a leadership […]

Clinical Trial demonstrates that nVNS is an effective learning acceleration tool while simultaneously improving focus and decreasing fatigue in study participants ROCKAWAY, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) published a paper entitled “Transcutaneous Cervical Vagus […]

NORCROSS, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D., an accomplished senior executive with expertise in liver disease to Chief Medical Officer effective immediately. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, […]

SPG302 is a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive function in people with Alzheimer’s disease LOS ANGELES, Aug. 01, 2024 (GLOBE NEWSWIRE) — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that enrollment is now […]

SANTA CLARA, Calif., Aug. 1, 2024 /PRNewswire/ — The Frost & Sullivan Institute is excited to unveil the 2024 Enlightened Leadership Best Practices Recognition winners from Middle East, Africa and Europe. These outstanding organizations have masterfully blended growth with their commitment to global stewardship. These exceptional companies, through their dedication to ‘innovating to zero’ to […]

PALO ALTO, Calif., Aug. 1, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it launched its highly anticipated short drama “Misplaced Love” on July 31st at FlexTV. Directed by a renowned vertical screen director and featuring a talented cast, this series blends the absurd with genuine emotion […]

HONG KONG , Aug. 1, 2024 /PRNewswire/ — Highway Holdings Limited (Nasdaq: HIHO) today reported financial results for the first quarter of fiscal year 2025 ended June 30, 2024. Net sales for the first quarter of fiscal year 2025 ended June 30, 2024 increased 39.3% to $1.88 million compared with $1.35 million in the first quarter […]